BACKGROUND: We sought to compare the differences of coefficient of fat absorption (CFA) and coefficient of nitrogen absorption (CNA) in healthy individuals and those with cystic fibrosis (CF) and to study the precision of CFA and CNA. METHODS: Sixteen healthy and 23 subjects with CF and pancreatic insufficiency ate a high-fat, high-protein diet for 72 hours; stool was collected between blue food dye markers to determine CFA and CNA. Subjects with CF withheld pancreatic enzymes. Tests were repeated on 5 of the CF and 10 of the healthy subjects. RESULTS: In healthy subjects, mean CFA was 93.5% ± 2.7%; mean CNA was 88.1% ± 5%. Median test-retest in 10 healthy subjects was +0.7% CFA (range, -8.1% to + 5.9%) and +0.9% CNA (range, -14.6% to +6.8%). For subjects with CF, mean CFA was 38.5% ± 14.7% and mean CNA was 52.2% ± 11.4%. Median test-retest change in 5 subjects with CF was -6.9% CFA (range, -19.7% to +42.8%) and +14.7% CNA (range, -6.4% to +42.8%). CONCLUSIONS: CFA and CNA have inconsistent precision in CF. The limitations of CFA as a measure of steatorrhea correction in CF should be recognized in studies of pancreatic enzyme supplements.
BACKGROUND: We sought to compare the differences of coefficient of fat absorption (CFA) and coefficient of nitrogen absorption (CNA) in healthy individuals and those with cystic fibrosis (CF) and to study the precision of CFA and CNA. METHODS: Sixteen healthy and 23 subjects with CF and pancreatic insufficiency ate a high-fat, high-protein diet for 72 hours; stool was collected between blue food dye markers to determine CFA and CNA. Subjects with CF withheld pancreatic enzymes. Tests were repeated on 5 of the CF and 10 of the healthy subjects. RESULTS: In healthy subjects, mean CFA was 93.5% ± 2.7%; mean CNA was 88.1% ± 5%. Median test-retest in 10 healthy subjects was +0.7% CFA (range, -8.1% to + 5.9%) and +0.9% CNA (range, -14.6% to +6.8%). For subjects with CF, mean CFA was 38.5% ± 14.7% and mean CNA was 52.2% ± 11.4%. Median test-retest change in 5 subjects with CF was -6.9% CFA (range, -19.7% to +42.8%) and +14.7% CNA (range, -6.4% to +42.8%). CONCLUSIONS:CFA and CNA have inconsistent precision in CF. The limitations of CFA as a measure of steatorrhea correction in CF should be recognized in studies of pancreatic enzyme supplements.
Authors: Drucy Borowitz; Christopher H Goss; Christopher Stevens; Denise Hayes; Laurie Newman; Anna O'Rourke; Michael W Konstan; Jeffrey Wagener; Richard Moss; Leslie Hendeles; David Orenstein; Richard Ahrens; Christopher M Oermann; Moira L Aitken; Thomas C Mahl; K Randall Young; Jordan Dunitz; Frederick T Murray Journal: Pancreas Date: 2006-04 Impact factor: 3.327
Authors: Drucy Borowitz; Peter R Durie; Lane L Clarke; Steven L Werlin; Christopher J Taylor; John Semler; Robert C De Lisle; Peter Lewindon; Steven M Lichtman; Maarten Sinaasappel; Robert D Baker; Susan S Baker; Henkjan J Verkade; Mark E Lowe; Virginia A Stallings; Morteza Janghorbani; Ross Butler; James Heubi Journal: J Pediatr Gastroenterol Nutr Date: 2005-09 Impact factor: 2.839
Authors: R C Stern; J D Eisenberg; J S Wagener; R Ahrens; M Rock; G doPico; D M Orenstein Journal: Am J Gastroenterol Date: 2000-08 Impact factor: 10.864
Authors: M W Konstan; R C Stern; J R Trout; J M Sherman; H Eigen; J S Wagener; C Duggan; M E B Wohl; P Colin Journal: Aliment Pharmacol Ther Date: 2004-12 Impact factor: 8.171
Authors: Michael W Konstan; Steven M Butler; Mary Ellen B Wohl; Marcia Stoddard; Robert Matousek; Jeffrey S Wagener; Charles A Johnson; Wayne J Morgan Journal: J Pediatr Date: 2003-06 Impact factor: 4.406
Authors: Mary Pat Francisco; Mary H Wagner; James M Sherman; Douglas Theriaque; Ellen Bowser; Donald A Novak Journal: J Pediatr Gastroenterol Nutr Date: 2002-07 Impact factor: 2.839
Authors: Drucy Borowitz; Susan S Baker; Linda Duffy; Robert D Baker; Laura Fitzpatrick; Joyce Gyamfi; Kerry Jarembek Journal: J Pediatr Date: 2004-09 Impact factor: 4.406
Authors: Jill Dorsey; Donna Buckley; Suzanne Summer; Ronald J Jandacek; Therese Rider; Patrick Tso; Michael R Narkewicz; James E Heubi Journal: J Pediatr Gastroenterol Nutr Date: 2010-04 Impact factor: 2.839
Authors: Virginia A Stallings; Joan I Schall; Asim Maqbool; Maria R Mascarenhas; Belal N Alshaikh; Kelly A Dougherty; Kevin Hommel; Jamie Ryan; Okan U Elci; Walter A Shaw Journal: J Pediatr Gastroenterol Nutr Date: 2016-12 Impact factor: 2.839
Authors: Maria R Mascarenhas; John Mondick; Jeffrey S Barrett; Martha Wilson; Virginia A Stallings; Joan I Schall Journal: J Clin Pharmacol Date: 2015-03-23 Impact factor: 3.126
Authors: Michael W Konstan; Drucy Borowitz; Nicole Mayer-Hamblett; Carlos Milla; Leslie Hendeles; Susan Murray; Richard A Kronmal; Susan Casey; Lynn M Rose; Wayne J Morgan; Bonnie W Ramsey Journal: Clin Investig (Lond) Date: 2013-08